ReviewProgress in cardiovascular diseases

Anti-consumption agents: Tirzepatide and semaglutide for treating obesity-related diseases and addictions, and improving life expectancy.

James H O'Keefe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.